Platelet-derived factors involved in tissue repair-from signal to function

Transfusion Medicine Reviews

Volumn 24, Issue 3, 2010, Pages 218-234

  Mazzucco, Laura ^a,b   Borzini, Piero ^a,b   Gope, Rajalakshmi ^a,b  

^a C Arrigo Children's Hospital   (Italy)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INOSITOL TRISPHOSPHATE; LATENCY ASSOCIATED PEPTIDE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; PROTEIN;

ARTICLE; BIOCHEMISTRY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; HEALTH PRACTITIONER; HUMAN; INTRACELLULAR SIGNALING; MITOGENESIS; NONHUMAN; SIGNAL TRANSDUCTION; TISSUE REPAIR; WOUND HEALING; CHEMISTRY; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

BLOOD PLATELETS; HUMANS; PROTEINS; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 77955099982     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2010.03.004     Document Type: Article

References (63)

1. Giusti I., Rughetti A., D'Ascenzo S., et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion 2009, 49:771-777.
2. Mishra A., Woodall J., Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 2009, 28:113-125.
3. Spyridakis M., Christodoulidis G., Chatzitheofilou C., et al. The role of the platelet-rich plasma in accelerating the wound-healing process and recovery in patients being operated for pilonidal sinus disease: Preliminary results. World J Surg 2009, 33:1764-1769.
4. Nikolidakis D., Jansen J.A. The biology of platelet-rich plasma and its application in oral surgery: Literature review. Tissue Eng Part B Rev 2008, 14:249-258.
5. Gope M.L., Gope R. Tyrosine phosphorylation of EGF-R and PDGF-R proteins during acute cutaneous wound healing process in mice. Wound Repair Regen 2009, 17:71-79.
6. Dohan Ehrenfest D.M., Rasmusson L., Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leukocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009, 27:158-167.
7. Jerne N.K. The generative grammar of the immune system. Nobel lecture, 8 December 1984. Biosci Rep 1985, 5:439-451. Available from:. http://nobelprize.org/nobel_prizes/medicine/laureates/1984/jerne-lecture.pdf.
8. Martin P., Parkhurst S.M. Parallels between tissue repair and embryo morphogenesis. Development 2004, 131:3021-3034.
9. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
10. Borzini P., Mazzucco L. Platelet-rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biologic view point?. ISBT Sci Ser 2007, 2:272-281.
11. Andrae J., Gallini R., Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008, 22:1276-1312.
12. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999, 79:1283-1316.
13. Tarsitano M., De Falco S., Colonna V., et al. The C. elegans pvf-1 gene encodes a PDGF/VEGF-like factor able to bind mammalian VEGF receptors and to induce angiogenesis. FASEB J 2006, 20:227-233.
14. Nissen N.N., Polverini P.J., Koch A.E., et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998, 152:1445-1452.
15. Barrientos S., Stojadinovic O., Golinko, et al. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
16. Martin P. Wound healing: Aiming for perfect skin regeneration. Science 1997, 276:75-81.
17. Pastore S., Mascia F., Mariani V., et al. The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 2008, 128:1365-1374.
18. Savage-Dunn C. TGF-β signaling. WormBook 2005, 9:1-12.
19. Huminiecki L., Goldovsky L., Freilich S., et al. Emergence, development and diversification of the TGF-β signaling pathway within the animal kingdom. BMC Evol Biol 2009, 9:1-17. Available:, via the INTERNET. Accessed June 19, 2009. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657120/?tool=pubmed.
20. Beenken A., Mohammadi M. The FGF family: Biology, pathophysiology and therapy. Nat Rev Drug Discov 2009, 8:235-253.
21. Upton Z., Yandell C.A., Degger B.G., et al. Evolution of insulin-like growth factor-I (IGF-1) action: In vitro characterization of vertebrate IGF-1 proteins. Comp Biochem Physiol B Biochem Mol Biol 1998, 121:35-41.
22. Barton E.R. The ABCs of IGF-1 isoforms: Impact on muscle hypertrophy and implications for repair. Appl Physiol Nutr Metab 2006, 31:791-797.
23. Attisano L., Wrana J.L. Signal transduction by the TGF-β superfamily. Science 2002, 296:1646-1647.
24. Marshall C.J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-185.
25. McKinnon R.D., Waldron S., Kiel M.E. PDGFα-receptor signal strength controls an RTK rheostat that integrates phosphoinositol 3'-kinase and phospholipase Cγ pathways during oligodendrocyte maturation. J Neurosci 2005, 25:3499-3508.
26. Ball S.G., Shuttleworth C.A., Kielty C.M. Mesenchymal stem cells and neovascularization: Role of platelet-derived growth factor receptors. J Cell Mol Med 2007, 11:1012-1030.
27. Olsson A.K., Dimberg A., Kreuger J., et al. VEGF receptor signaling-in control of vascular function. Nat Rev Mol Cell Biol 2006, 7:359-371.
28. Bussolino F., Serini G., Mitola S., et al. Dynamic modules and heterogeneity of function: A lesson from tyrosine kinase receptors in endothelial cells. EMBO Rep 2001, 2:763-767.
29. Feng X.H., Derynck R. Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 2005, 21:659-693.
30. Moustakas A., Heldin C.H. Dynamic control of TGF-β signaling and its links to the cytoskeleton. FEBS Lett 2008, 582:2051-2065.
31. Amagasaki K., Kaneto H., Heldin C.H., et al. c-Jun N-terminal kinase is necessary for platelet-derived growth factor-mediated chemotaxis in primary fibroblasts. J Biol Chem 2006, 281:22173-22179.
32. Schmahl J., Raymond C.S., Soriano P. PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet 2007, 39:52-60.
33. Sahni A., Francis C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000, 96:3772-3778.
34. Cao R., Bråkenhielm E., Pawliuk R., et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003, 9:604-613.
35. Kano M.R., Morishita Y., Iwata C., et al. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 2005, 118:3759-3768.
36. Tanimoto T., Lungu A.O., Berk B.C. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ Res 2004, 94:1050-1058.
37. Natarajan K., Berk B.C. Cross talk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. Methods Mol Biol 2006, 332:51-77.
38. New D.C., Wong Y.H. Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. J Mol Signal 2007, 2:1-15. Available:, via the INTERNET. Accessed June 19, 2009. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808056/?tool=pubmed.
39. Xu K.P., Yin J., Yu F.S. Src-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2006, 47:2832-2839.
40. Ashcroft G.S., Yang X., Glick A.B., et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999, 1:260-266.
41. Kip-1. FASEB J 2006, 20:E1037-E1048.
42. Harmer N.J. Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem Soc Trans 2006, 34:442-445.
43. Sahni A., Sahni S.K., Simpson-Haidaris P.J., et al. Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells. J Thromb Haemost 2004, 2:1629-1636.
44. Baxter R.C., Martin J.L., Beniac V.A. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. J Biol Chem 1989, 264:11843-11848.
45. Schlueter P.J., Royer T., Farah M.H., et al. Gene duplication and functional divergence of the zebrafish insulin-like growth factor 1 receptors. FASEB J 2006, 20:E462-E471.
46. Chetty A., Cao G.J., Nielsen H.C. Insulin-like growth factor-I signaling mechanisms, type I collagen and alpha smooth muscle actin in human fetal lung fibroblasts. Pediatr Res 2006, 60:389-394.
47. Stitt T.N., Drujan D., Clarke B.A., et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004, 14:395-403.
48. Carter M.E., Brunet A. FOXO transcription factors. Curr Biol 2007, 17:R113-R114.
49. Chan K., Spencer E.M. Megakaryocytes endocytose insulin-like growth factor (IGF) I and IGF-binding protein-3: A novel mechanism directing them into alpha granules of platelets. Endocrinology 1998, 139:559-565.
50. Payet L.D., Firth S.M., Baxter R.C. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. J Clin Endocrinol Metab 2004, 89:2382-2389.
51. Campbell P.G., Durham S.K., Hayes J.D., et al. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. J Biol Chem 1999, 274:30215-30221.
52. Vogt P.M., Lehnhardt M., Wagner D., et al. Determination of endogenous growth factors in human wound fluid: Temporal presence and profiles of secretion. Plast Reconstr Surg 1998, 102:117-123.
53. Su C.Y., Kuo Y.P., Nieh H.L., et al. Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 2008, 48:2414-2420.
54. Nam T.J., Busby W.H., Rees C., et al. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-1-stimulated cell growth. Endocrinology 2000, 141:1100-1106.
55. Giacco F., Perruolo G., D'Agostino E., et al. Thrombin-activated platelets induce proliferation of human skin fibroblasts by stimulating autocrine production of insulin-like growth factor-1. FASEB J 2006, 20:2402-2404.
56. Guo X., Wang X.F. Signaling cross-talk between TGFβ/BMP and other pathways. Cell Res 2009, 19:71-88.
57. Chase A.J., Newby A.C. Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: A multi-step recruitment model for pathological remodelling. J Vasc Res 2003, 40:329-343.
58. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: Molecular and cellular mechanisms. J Invest Dermatol 2007, 127:514-525.
59. Agren M.S., Steenfos H.H., Dabelsteen S., et al. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999, 112:463-469.
60. Seah C.C., Phillips T.J., Howard C.E., et al. Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway. J Invest Dermatol 2005, 124:466-474.
61. Fadiga L., Craighero L., D'Ausilio A. Broca's area in language, action, and music. Ann N Y Acad Sci 2009, 1169:448-458.
62. Lu H.H., Vo J.M., Chin H.S., Lin J., et al. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J Biomed Mater Res A 2008, 86:1128-1136.
63. de Vos R.J., Weir A., van Schie H.T., et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 2010, 303:144-149.